Graeme has more than 20 years of healthcare and life sciences experience including senior commercial, strategy and general management roles at GlaxoSmithKline, IVAX Pharmaceuticals, and Healthcare at Home. Prior to accepting the Chief Executive Officer role at ADVANZ PHARMA, Graeme previously served as President of ADVANZ PHARMAs International segment since January 2016. Prior to his role as President, he was Managing Director for ADVANZ PHARMA's International segment.

Adeel brings over 20 years of experience in the pharmaceutical, distribution, telecommunications and accounting industries. Prior to becoming the Chief Financial Officer of ADVANZ PHARMA, Adeel was CFO of the Company’s International segment, and before that, Vice President, Finance and Controller of the Company. Prior to joining the company in 2013, Adeel was the Chief Financial Officer of the Indian operations of Ingram Micro Mobility (formerly BrightPoint), based in New Delhi, India, from February 2012 to May 2013. Prior to his role at BrightPoint, Mr. Ahmad held several finance roles of increasing responsibility with Nortel Networks from 2003 to 2012, based in Brampton, Ontario, Canada; Seoul, South Korea; and Beijing, China. Adeel started his career in an audit function with Deloitte LLP in Toronto. He holds a B. Comm from the University of Toronto and an MBA from the Ivey School of Business, University of Western Ontario.

Karl has more than 30 years of experience in manufacturing, packaging, supply chain and distribution, and 20 years in senior management and leadership positions including his role as Operations Director for Teva. As Chief Operations Officer for ADVANZ PHARMA, Karl leads all operations functions globally, including scientific affairs (medical, regulatory and quality), supply (supply chain and supplier alliance management), new product introductions and technical operations.

Paul joined ADVANZ PHARMA from Teva in September 2016 in the role of Vice President UK&I Commercial. His diverse commercial career spans 20 years and also includes marketing and commercial strategy roles at Smiths Medical Systems, IVAX Pharmaceuticals, Merck Generics (Mylan) and Arrow Generics (Watson Pharmaceuticals). In 2009 Paul moved into consultancy working as a Director at Fleishman-Hillard (an Omnicom communications consultancy), where he managed international communications programmes for Bristol Myers Squibb and Philips. In 2013, he joined Teva, where he had board level responsibility for the largest generics business in the UK. As Chief Commercial Officer of the Strategic Growth Unit, Paul leads the commercial operations in the UK & Ireland, our in-market sales & marketing capabilities across Europe and the Corporate Communications function.

Susanna brings over 15 years of leadership experience in the pharmaceutical industry, specialising in leading buy and build initiatives, transformational turnarounds, organic pipeline development, and devising and implementing strategic plans for geographic expansion. Susanna is responsible for M&A, BD&L and Data and Market Intelligence at ADVANZ and will drive the development and execution of the company’s growth plans.

Prior to joining ADVANZ, she played a pivotal role in the establishment and growth of PE-backed Theramex, where she was part of the core management team who carved-out more than 20 assets across multiple geographies to create a stand-alone specialty pharmaceutical company.

Fiona Huzarski has worked for over 20 years as a senior HR professional, 15 years within the Pharmaceuticals industry. As Vice President of Global HR, she is responsible for leading the Global HR function and setting the People Strategy to create an inclusive, flexible and collaborative environment where all employees can grow and develop in support of the company’s long-term goals.

Prior to joining ADVANZ PHARMA as Vice President of Global HR in August 2019, she was Global HR Director at Britannia Pharmaceuticals, part of the STADA group. Her career started in the Management Consulting sector before joining GSK’s Global Recruitment Team and working for 10 years at UCB in various Senior HR roles, supporting the Commercial, R&D and Technical Operations functions in both UK & Ireland and across Europe. She is a Fellow of the Chartered Institute of Personnel & Development (CIPD) and holds a Post graduate Diploma in Human Resource Management from Thames Valley University.

Anke joined ADVANZ PHARMA in October 2021. She brings over 15 years’ experience from strategic and operational management positions in the pharmaceutical and consulting industry and will be essential in leading the company’s transformation journey as it continues its expansion focusing on commercialising complex medicines in Europe to even better serve our patients and customers.

A pharmacist by training, she holds a PhD in molecular biology. Prior to joining ADVANZ PHARMA, Anke worked at McKinsey, HgCapital and most recently, held various global roles across Strategy, Launch and Portfolio Management as well building and driving the local German ehealth Strategy at Sandoz.

Rob is an experienced General Counsel and corporate lawyer. He worked in London for 11 years for an international law firm before joining AMCo in 2011. As General Counsel during 2011-2016 he ran the legal, company secretarial and corporate communications teams. He was at the forefront of all M&A and he led all post-acquisition integration projects, including the merger of Amdipharm and Mercury Pharma during 2012-13 to create AMCo, and the integrations of Abcur (Sweden), Focus Pharma (UK), Primegen (UK) and BnM (Australia) into AMCo in 2013-2015. He led the integration of the International and North American divisions of Advanz Pharma in 2015-2016 and managed the Group’s regulatory disputes. He was appointed as Global General Counsel in 2018.

Simon started his pharmaceutical career as a Medical Representative with Pfizer Ltd in the UK. In 2000 he joined Goldshield and held various International Regional Management positions in the Middle East, Asia and Europe. He then joined the International division of Stiefel Laboratories with particular focus on the Middle East and Africa. Simon joined Amdipharm in 2006 and was instrumental in establishing its Latin American business. In 2011, he became the Director of Alliance Management and in 2013 he was appointed International Commercial Director. As President, International & North America Simon leads our commercial operations in these regions.

Dr Nick Warwick has over 30 years of experience both in the pharmaceutical industry and as a medical doctor. Nick trained as a medical Doctor at Charing Cross Hospital Medical School in London, now part of the Imperial College group, and spent 10 years in clinical medicine rotating through disciplines including emergency medicine, rheumatology and rehabilitation, dermatology, ear nose and throat surgery, obstetrics and gynaecology, and primary care, before joining the Pharmaceutical Industry in 1997 as Medical Adviser for Abbott. In the following 24 years, Nick held senior country level, regional and global leadership roles within Medical Affairs and Clinical Development (Abbott and Abbvie) and was Chief Medical Officer for Sandoz (2014-2019). Nick joined ADVANZ PHARMA as Chief Medical Officer in June 2020. He is responsible for setting the medical vision and strategic direction for the Medical Office (comprising medical affairs, patient safety, clinical development and medical compliance functions), ensuring that ADVANZ PHARMA has the right resources, skills and capabilities to meet its growing business needs and that the voice of the patient and healthcare professional is fully represented in all company decisions.

Nick holds a Bachelor of Medicine, Bachelor of Surgery from Charing Cross Hospital Medical School, London (MBBS, 1986), and a Diploma from the Royal College of Obstetrics and Gynaecologists, London (DRCOG, 1992) and a Diploma of Pharmaceutical Medicine from the University of Wales, Cardiff (DPM, 1998). He has been a Fellow of the Faculty of Pharmaceutical Physicians (FFPM) since 2010.

Graeme has more than 20 years of healthcare and life sciences experience including senior commercial, strategy and general management roles at GlaxoSmithKline, IVAX Pharmaceuticals, and Healthcare at Home. Prior to accepting the interim Chief Executive Officer role at ADVANZ PHARMA, Graeme previously served as President of ADVANZ PHARMA’s International segment since January 2016. Prior to his role as President, he was Managing Director for ADVANZ PHARMA’s International segment.

Mr. Ahmad has more than 20 years of experience in the pharmaceutical, distribution, telecommunications and accounting industries. Prior to becoming the CFO of ADVANZ PHARMA in June 2018, Mr. Ahmad was CFO of the Company's International segment, and before that, Vice President, Finance and Controller of the Company.